ArticleAmerican journal of clinical and experimental urology2014

Growth of LAPC4 prostate cancer xenograft tumor is insensitive to 5α-reductase inhibitor dutasteride.

Raquel Ramos Garcia et al.PubMed ↗Full text ↗

No numbers read from the abstract.